Cancer – ALTE11C2: Health Effects After Anthracycline and Radiation Therapy (HEART): Dexrazoxane and Prevention of Anthracycline-Related Cardiomyopathy
Condition or Therapy:
Hodgkin lymphoma, osteosarcoma
Cancer and Blood Disorders
Study Number: ALTE11C2
What is the goal of this study?
This trial looks at how well dexrazoxane hydrochloride affects biomarkers with cardiomyopathy and heart failure after cancer treatment.
Who can join the study?
This study may be a good fit for children and young adults who:
- are any age, and
- are leukemia or lymphoma survivors.
What will happen if my child takes part in this study?
You can read more about this study on clinicaltrials.gov.
Who can I contact for more information?
To learn more, call 206-987-2106 or email the study coordinator.